MA49464A - Targeted drug rescue avec de nouvelles compositions, associations et procédés correspondants - Google Patents

Targeted drug rescue avec de nouvelles compositions, associations et procédés correspondants

Info

Publication number
MA49464A
MA49464A MA049464A MA49464A MA49464A MA 49464 A MA49464 A MA 49464A MA 049464 A MA049464 A MA 049464A MA 49464 A MA49464 A MA 49464A MA 49464 A MA49464 A MA 49464A
Authority
MA
Morocco
Prior art keywords
associations
corresponding processes
targeted drug
new compositions
drug rescue
Prior art date
Application number
MA049464A
Other languages
English (en)
Inventor
Anton Bespalov
Hans J Moebius
Sreenivasarao Vepachedu
Original Assignee
Exciva GmbH
Sreenivasarao Vepachedu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from TW106129169A external-priority patent/TW201815387A/zh
Application filed by Exciva GmbH, Sreenivasarao Vepachedu filed Critical Exciva GmbH
Publication of MA49464A publication Critical patent/MA49464A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
MA049464A 2017-05-04 2018-05-03 Targeted drug rescue avec de nouvelles compositions, associations et procédés correspondants MA49464A (fr)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201762501696P 2017-05-04 2017-05-04
TW106129169A TW201815387A (zh) 2016-08-26 2017-08-28 組成物及其方法
US201862634162P 2018-02-22 2018-02-22
US201862636099P 2018-02-27 2018-02-27
US201862635554P 2018-02-27 2018-02-27
US201862636171P 2018-02-28 2018-02-28

Publications (1)

Publication Number Publication Date
MA49464A true MA49464A (fr) 2020-04-29

Family

ID=65431106

Family Applications (1)

Application Number Title Priority Date Filing Date
MA049464A MA49464A (fr) 2017-05-04 2018-05-03 Targeted drug rescue avec de nouvelles compositions, associations et procédés correspondants

Country Status (13)

Country Link
EP (1) EP3618819A4 (fr)
JP (2) JP7514078B2 (fr)
KR (2) KR102444803B1 (fr)
CN (1) CN110831584B (fr)
AU (2) AU2018261654A1 (fr)
BR (1) BR112019022902A2 (fr)
CA (2) CA3138116A1 (fr)
IL (1) IL270326B2 (fr)
MA (1) MA49464A (fr)
RU (1) RU2760558C9 (fr)
TW (1) TWI787260B (fr)
WO (1) WO2018204713A1 (fr)
ZA (1) ZA201908006B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2018261654A1 (en) * 2017-05-04 2019-11-14 Exciva GmbH Targeted drug rescue with novel compositions, combinations, and methods thereof
CN113825510A (zh) * 2019-03-18 2021-12-21 阿瓦尼尔制药股份有限公司 使用氘化右美沙芬和奎尼丁治疗精神分裂症的阴性症状的方法
JP7400818B2 (ja) * 2019-06-06 2023-12-19 Jsr株式会社 感放射線性樹脂組成物、レジストパターン形成方法及び化合物
EP4153564A4 (fr) 2020-05-19 2024-06-19 Cybin IRL Limited Dérivés de tryptamine deutérés et procédés d'utilisation
CN116473077B (zh) * 2023-05-08 2025-04-11 广东方中高新材料有限公司 一种n,n配位的镓配合物抗菌剂的合成和应用
CN116473073A (zh) * 2023-05-08 2023-07-25 广东方中高新材料有限公司 一种含镓配合物的吡唑醚菌酯增效悬浮制剂及其制备方法
CN119432479B (zh) * 2023-08-04 2025-10-03 中国石油天然气股份有限公司 柴油机润滑油组合物及其制备方法
CN120987847B (zh) * 2024-11-29 2026-02-17 江苏恩华药业股份有限公司 一种氢溴酸右美沙芬的制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4241065A (en) * 1979-07-02 1980-12-23 E. I. Du Pont De Nemours And Company Fluoro analogs of hydrocodone and oxycodone useful as analgesics, narcotic antagonists or both
US4950658A (en) * 1988-12-06 1990-08-21 Board Of Trustees Of Southern Illinois Univ. Method of medical treatment of Alzheimer's disease
US5891885A (en) 1996-10-09 1999-04-06 Algos Pharmaceutical Corporation Method for treating migraine
US6207674B1 (en) 1999-12-22 2001-03-27 Richard A. Smith Dextromethorphan and oxidase inhibitor for weaning patients from narcotics and anti-depressants
US6335371B1 (en) * 2000-11-28 2002-01-01 Orion Corporation Method for inducing cognition enhancement
TWI326214B (en) * 2002-07-17 2010-06-21 Avanir Pharmaceuticals Inc Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders
US20070099947A1 (en) * 2005-11-03 2007-05-03 Alkermes, Inc. Methods and compositions for the treatment of brain reward system disorders by combination therapy
KR20080097443A (ko) 2006-02-03 2008-11-05 아바니르 파마슈티컬스 덱스트로메토판 및 퀴니딘을 포함하는, 우울, 불안 및 신경퇴행성 장애 치료용 약제학적 조성물
PL2345653T3 (pl) * 2007-05-01 2013-05-31 Concert Pharmaceuticals Inc Związki morfianu
WO2008144764A1 (fr) * 2007-05-21 2008-11-27 Reviva Pharmaceuticals, Inc. Compositions, synthèses et procédés d'utilisation d'agents antipsychotiques atypiques à base de quinolinone
US8017623B2 (en) * 2008-07-03 2011-09-13 Trinity Laboratories, Inc. Dextromethorphan hydrochloride
US9737531B2 (en) * 2012-07-12 2017-08-22 Glytech, Llc Composition and method for treatment of depression and psychosis in humans
US10716784B2 (en) 2013-03-07 2020-07-21 Mindlab LLC Pain medicine combination and uses thereof
EP2972329A2 (fr) 2013-03-15 2016-01-20 Kinemed, Inc. Biomarqueurs
JP2017531033A (ja) * 2014-09-14 2017-10-19 アヴェニール ファーマシューティカルズ， インコーポレイテッド 認知症における激越の処置のためのデキストロメトルファン化合物およびキニジンを含む医薬組成物
RU2764716C2 (ru) * 2016-08-26 2022-01-19 Экссива Уг (Хафтунгзбешрэнкт) Композиции и связанные с ними способы
AU2018261654A1 (en) * 2017-05-04 2019-11-14 Exciva GmbH Targeted drug rescue with novel compositions, combinations, and methods thereof

Also Published As

Publication number Publication date
EP3618819A1 (fr) 2020-03-11
KR20210130827A (ko) 2021-11-01
AU2021215274B2 (en) 2022-11-03
CN110831584B (zh) 2023-03-10
JP2020518617A (ja) 2020-06-25
RU2019137004A (ru) 2021-06-04
CA3062452C (fr) 2023-10-24
CA3062452A1 (fr) 2018-11-08
IL270326A (fr) 2018-05-03
EP3618819A4 (fr) 2021-01-20
IL270326B2 (en) 2023-02-01
JP7514078B2 (ja) 2024-07-10
KR20200062078A (ko) 2020-06-03
AU2021215274A1 (en) 2021-09-02
TW201842902A (zh) 2018-12-16
BR112019022902A2 (pt) 2020-05-19
IL270326B (en) 2022-10-01
JP2023143940A (ja) 2023-10-06
RU2760558C2 (ru) 2021-11-29
CN110831584A (zh) 2020-02-21
RU2760558C9 (ru) 2022-02-22
AU2018261654A1 (en) 2019-11-14
KR102444803B1 (ko) 2022-09-19
RU2019137004A3 (fr) 2021-06-04
WO2018204713A1 (fr) 2018-11-08
CA3138116A1 (fr) 2018-11-08
ZA201908006B (en) 2021-04-28
TWI787260B (zh) 2022-12-21

Similar Documents

Publication Publication Date Title
MA49464A (fr) Targeted drug rescue avec de nouvelles compositions, associations et procédés correspondants
EP3313989C0 (fr) Arn crispr modifié et arn crispr simple modifié et utilisations correspondantes
EP3397757A4 (fr) Nouvelles transposases associées à crispr et leurs utilisations
MA49858A (fr) Composés, compositions et procédés
DK3297637T3 (da) Benzen-1,3,5-tricarboxamidderivater og anvendelser deraf
HUE054103T2 (hu) Izokinolin-3-il-karboxamidok, ezek elõállítása és alkalmazása
HUE067016T2 (hu) Önfeláldozó csoportokat tartalmazó konjugátumok és ezekkel kapcsolos eljárások
HUE053737T2 (hu) Piridopirrolokinoxalin vegyületek, készítményeik és alkalmazásaik
EP3313530A4 (fr) Dérivés de 4,6-pyrimidinylène et utilisations de ceux-ci
MA50063A (fr) Composés, compositions et procédés
EP3551238A4 (fr) Compositions désodorisantes, dispositifs de stomie et leurs utilisations
HUE049081T2 (hu) GP120 elleni neutralizáló antitestek és alkalmazásuk
EP3313404A4 (fr) Compositions thérapeutiques, associations et procédés d'utilisation
EP3599868C0 (fr) Mélange herbicide, composition et procédé
EP3535204A4 (fr) Installation de stockage en libre-service, fabrication, et méthodologie
EP3500255A4 (fr) Compositions pharmaceutiques ophtalmiques et utilisations associées
EP3685828A4 (fr) Composition pharmaceutique ophtalmique, trousse ophtalmique et application pharmaceutique associée
EP3515897A4 (fr) Carbamates de pipérazine, procédés de préparation et utilisation de ceux-ci
EP3617287A4 (fr) Agent épaississant, composition et feuille
EP3562942A4 (fr) Crispr-arn modifié et ses utilisations
HUE060805T2 (hu) Piridinamin-piridon és pirimidinamin-piridon vegyületek
EP3434285A4 (fr) Composition pharmaceutique et ses utilisations
DK3612579T3 (da) Pultrudat, fremstilling og anvendelse heraf
EP3654982A4 (fr) Composés de 1,8-naphthyridinone et leurs utilisations
EP3609504A4 (fr) Nouveaux analogues d'oxaborole et utilisations de ces derniers